Pharmaceutical giant Pfizer has recalled one million packs of birth control pills that may not contain enough contraception to prevent pregnancy. While the recalled pills do not pose a health threat they could leave women at risk of unintended pregnancies.
A press release issued by Pfizer
stated the company "recalled 14 lots of Lo/Ovral®-28 (norgestrel and ethinyl estradiol)Tablets and 14 lots of Norgestrel and Ethinyl Estradiol Tablets (generic)for customers in the U.S. market."
The Daily Mail
reported that a Pfizer spokesperson confirmed that a packaging mix up caused by mechanical and visual failure resulted in some packets of the contraceptive pills having too much of the active contraceptive ingredients, and others too little.
Pfizer voluntarily recalled the contraceptive pills at a time when the company has just announced a 50 percent reduction in profits in the fourth quarter of 2011. Philly.com
reported that the company experienced flat revenue against the backdrop of a declining work force, but the biggest fall in profits was due to the decline in demand for the cholesterol drug Lipitor.